To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@mail.nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CSP-1026

Division
DTMC
HEAL Study
No
Investigator(s)
Ahmed Elkashef, M.D.
Title
Phase 2, Double-Blind, Placebo-Controlled Trial Of Modafinil For Methamphetamine Dependence
Short Description
To evaluate the efficacy and safety of modafinil in reducing methamphetamine use in subjects with methamphetamine dependence.
Release Date
Sep 02, 2015
Description

The primary objective of this study is to assess the efficacy of modafinil in increasing the number of methamphetamine non-use weeks in subjects with methamphetamine dependence

Keywords
phase 2b
modafinil
methamphetamine
stimulant
Assessments
Addiction Severity Index Lite
Adult ADHD Investigator Symptom Rating Scale
Barratt Impulsiveness Scale
Brief Substance Craving Scale
Clinical Global Impression Scales
Substance Use Report
Urine Methamphetamine Level
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links
Study Information
CSP-1026 Study Information